Aculeus Therapeutics Announces New Head of Immunobiology
November 29, 2021
Read more
SYNthesis welcomes Martine Keenan as Chief Innovation Officer
August 30, 2021
Read more
SYNthesis founded Venture Aculeus Therapeutics announces new logo and website
June 30, 2021
AculeusTx.com
New Venture Manager joins SYNthesis team
May 10, 2021
Read more
SYNthesis med chem acquired by Viva Biotech for USD 80M
September 20, 2020
Read more
SYNthesis investee organisation Cancer Therapeutics CRC signs 2-year deal with Pfizer
October 26, 2018
cancercrc.com